Program Goals

Click here to register for this event

With an emphasis on diagnosis, this activity will provide a review of the clinical signs and symptoms and the pathogens involved in viral respiratory infections. Viral diagnostic test methodologies will be compared and workflow issues will be discussed. Diagnostic test implementation and interpretation will be reviewed as well as the potential clinical outcome benefits.

Target Audience

Healthcare workers, especially clinical laboratory professionals involved in laboratory diagnostic testing will be the primary attendees at this educational session. The estimated audience size for this ASCLS Keynote Session is approximately 500 – 1000 healthcare professionals.

Educational Objectives

Upon completion of this activity, participants should be able to:

  1. Review epidemiology of respiratory viral pathogens and reliability of clinical signs and symptoms for diagnosis of viral etiologies
  2. Discuss differences in performance parameters of diagnostic test methodologies for viral diagnosis. Comparisons of molecular, culture/ DFA and rapid tests and workflow issues
  3. Review of the potential clinical outcome benefits and issues with implementation and interpretation

Faculty

Kimberle C. Chapin, MD
Director of Microbiology and Molecular Diagnostics
Lifespan Academic Medical Centers
Professor of Medicine and Pathology
Brown Medical School
Providence, RI

Agenda

- 02 minutes: Welcome and Faculty Introduction
- 43 minutes: Faculty Presentations
- 12 minutes: Q&A Session
- 03 minutes: Conclusion, and Credit Application Info

 

Disclosure of Conflicts of Interest

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosure Summary

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. adhere to established standards regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known below.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.® accredited activity: 

NAME TYPE COMMERCIAL SUPPORTER
Kimberle C. Chapin, MD Grant / Research Support Gen - Probe, Cepheid, Trek DS, BD, Gen - Mark
Consultant /
Independent Contractor
Trek DS
Speakers Bureau Gen - Probe, Trek DS

Planners and Managers

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.® accredited activity:

 

ASCLS - Name of Planner or Manager Reported Financial Relationship
Sherry Miner Nothing to disclose
DGL - Name of Planner or Manager Reported Financial Relationship
LaRue Highsmith Nothing to disclose
(Spouse - no planning role) Admin: Abbott Laboratories

Credit Designation - Lab Professional, P.A.C.E.®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.0 contact hour of credit.

How to Obtain P.A.C.E.® Credit

PACE_Logo.jpg

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed by July 28, 2011.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast: 

  • Read all of the information above.
  • View the complete webcast program.
  • Click on the "Lab Professional" link to apply for P.A.C.E.® credit.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive P.A.C.E.® credit.
  • After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.® approved learning activity.

 Should you have any P.A.C.E.® questions regarding this activity, please contact:

ASCLS P.A.C.E.®
2025 M Street NW, Suite 800
Washington DC 20036
Ph: 202-367-1174
Fx: 202-367-2174
http://www.ascls.org/

P.A.C.E.® Release and Expiration Dates

Enduring Archive Release Date: TBD
Enduring Archive P.A.C.E.® Expiration date: TBD

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Clinical Laboratory Science (ASCLS) and Dane Garvin Ltd. (DGL) do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. protect the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Additionally, personal information will not be released to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available in a live symposium and online.

"Improving Clinical and Therapeutic Outcomes for Respiratory Viral Infection using Multiplex PCR"

System Requirements

For technical difficulties, please consult our Technical Instructions.

Commercial Support Statement

    This activity supported by an educational grant from Abbott Molecular.

Abbott_logo.png  This activity supported by an educational grant from Abbott Molecular.

 

Luminex.jpg  This activity has been supported by an educational grant from Luminex.

Copyright

Copyright © 2011 - 2013. Dane Garvin, Ltd.   All Rights Reserved.   Permission for accreditation is granted to the American Society for Clinical Laboratory Science.